There is substantial evidence to support the contention that the Smad porti
on of the TGF-beta signal transduction pathway provides an important tumor-
suppressor function. Mutational loss of function of Smad pathway members ha
ve been associated with the development of human cancers and appear to be c
ausative in selected rodent carcinogenesis models. TGF-beta also has multip
le other actions that appear to be independent of the growth-inhibitory/tum
or suppressor effects. The predominant effect of TGF-beta appears to be dep
endent on the context of the responding cell. Once transformation has occur
red, TGF-beta effects may be detrimental and may actually promote tumor cel
l survival, invasion, and metastasis. Recent work suggests that these effec
ts may involve TGF-beta regulation of COX-2 and other pathways that may con
tribute to tumor cell aggressiveness. In gaining a better understanding of
the mechanisms by which TGF-beta may promote tumor progression, it is likel
y that new therapeutic strategies may be developed that preserve tumor-supp
ressor function of TGF-beta while inhibiting the tumor-promoting effects. M
icrosc. Res. Tech. 52: 450-457, 2001. (C) 2001 Wiley-Liss, Inc.